{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:14:10Z","timestamp":1783498450741,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2145 SyNergy ID 390857198"],"award-info":[{"award-number":["EXC 2145 SyNergy ID 390857198"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00415-026-13913-y","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:21:26Z","timestamp":1781166086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of a novel homozygous CTSD variant causing adult-onset neuronal ceroid lipofuscinosis type 10: a case report"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9980-9981","authenticated-orcid":false,"given":"Lena","family":"Marth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 R. A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheyl","family":"Noachtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"R\u00e9mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endy","family":"Weidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Sch\u00f6berl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes S.","family":"Gn\u00f6rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Biskup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4492-7302","authenticated-orcid":false,"given":"Georg","family":"Nuebling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"13913_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105729","volume":"23","author":"K Kamini\u00f3w","year":"2022","unstructured":"Kamini\u00f3w K, Kozak S, Paprocka J (2022) Recent insight into the genetic basis, clinical features, and diagnostic methods for neuronal ceroid lipofuscinosis. Int J Mol Sci 23:5729","journal-title":"Int J Mol Sci"},{"key":"13913_CR2","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/febs.13980","volume":"284","author":"S Ketterer","year":"2017","unstructured":"Ketterer S et al (2017) Inherited diseases caused by mutations in cathepsin protease genes. FEBS J 284:1437\u20131454","journal-title":"FEBS J"},{"key":"13913_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0887-8994(92)90054-3","volume":"8","author":"RJ Barohn","year":"1992","unstructured":"Barohn RJ, Dowd DC, Kagan-Hallet KS (1992) Congenital ceroid-lipofuscinosis. Pediatr Neurol 8:54\u201359","journal-title":"Pediatr Neurol"},{"key":"13913_CR4","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/mds.28106","volume":"35","author":"M Regensburger","year":"2020","unstructured":"Regensburger M et al (2020) Novel Biallelic CTSD Gene Variants Cause Late-Onset Ataxia and Retinitis Pigmentosa. Mov Disord 35:1280\u20131282","journal-title":"Mov Disord"},{"key":"13913_CR5","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1086\/504159","volume":"78","author":"R Steinfeld","year":"2006","unstructured":"Steinfeld R et al (2006) Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet 78:988\u2013998","journal-title":"Am J Hum Genet"},{"key":"13913_CR6","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1212\/WNL.0000000000000981","volume":"83","author":"J Hersheson","year":"2014","unstructured":"Hersheson J et al (2014) Cathepsin D deficiency causes juvenile-onset ataxia and distinctive muscle pathology. Neurology 83:1873\u20131875","journal-title":"Neurology"},{"key":"13913_CR7","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/brain\/awl107","volume":"129","author":"E Siintola","year":"2006","unstructured":"Siintola E (2006) Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129:1438\u20131445","journal-title":"Brain"},{"key":"13913_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-008-0426-7","volume":"117","author":"K Fritchie","year":"2009","unstructured":"Fritchie K et al (2009) Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10). Acta Neuropathol 117:201\u2013208","journal-title":"Acta Neuropathol"},{"key":"13913_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/15548627.2019.1637200","volume":"16","author":"ARA Marques","year":"2020","unstructured":"Marques ARA et al (2020) Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis. Autophagy 16:811\u2013825","journal-title":"Autophagy"},{"key":"13913_CR10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/15548627.2019.1637200","volume":"16","author":"ARA Marques","year":"2020","unstructured":"Marques ARA et al (2020) Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis. Autophagy 16:811\u2013825","journal-title":"Autophagy"},{"key":"13913_CR11","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","volume":"131","author":"D Reczek","year":"2007","unstructured":"Reczek D et al (2007) LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 131:770\u2013783","journal-title":"Cell"},{"key":"13913_CR12","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.1073\/pnas.90.14.6796","volume":"90","author":"ET Baldwin","year":"1993","unstructured":"Baldwin ET et al (1993) Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc Natl Acad Sci U S A 90:6796\u20136800","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13913_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-19","volume":"8","author":"FM Santorelli","year":"2013","unstructured":"Santorelli FM et al (2013) Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy. Orphanet J Rare Dis 8:19","journal-title":"Orphanet J Rare Dis"},{"key":"13913_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jms.4675","volume":"56","author":"S Maeser","year":"2021","unstructured":"Maeser S et al (2021) Enzymatic diagnosis of neuronal lipofuscinoses in dried blood spots using substrates for concomitant tandem mass spectrometry and fluorimetry. J Mass Spectrom 56:e4675","journal-title":"J Mass Spectrom"},{"key":"13913_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01443-6","volume":"16","author":"HM Terron","year":"2024","unstructured":"Terron HM et al (2024) Prominent tauopathy and intracellular \u03b2-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis. Alzheimers Res Ther 16:70","journal-title":"Alzheimers Res Ther"},{"key":"13913_CR16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S1357-2725(99)00053-9","volume":"31","author":"G Sadik","year":"1999","unstructured":"Sadik G et al (1999) In vitro processing of amyloid precursor protein by cathepsin D. Int J Biochem Cell Biol 31:1327\u20131337","journal-title":"Int J Biochem Cell Biol"},{"key":"13913_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105919","volume":"175","author":"L Gallwitz","year":"2022","unstructured":"Gallwitz L et al (2022) Cathepsin D: analysis of its potential role as an amyloid beta degrading protease. Neurobiol Dis 175:105919","journal-title":"Neurobiol Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13913-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13913-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13913-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:22:00Z","timestamp":1783495320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13913-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["13913"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13913-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L.M., F.S., E.W., S.N., K.E., J.R., S.B., S.G., and G.N. report no disclosures relevant to this work. M.B. is a member of the Neuroimaging Committee of the EANM. M.B. has received speaker honoraria from Roche, GE Healthcare, Iba, Miltenyi, and Life Molecular Imaging; has advised Life Molecular Imaging, MIAC, Cenos, and GE healthcare; and is currently in the advisory or imaging review boards of AC Immune and ZRO Imaging. J.L. reports speaker fees from Bayer Vital, Biogen, EISAI, TEVA, Zambon, Esteve, Merck and Roche, consulting fees from Axon Neuroscience, EISAI and Biogen, author fees from Thieme medical publishers and W. Kohlhammer GmbH medical publishers and is inventor in a patent \u201cOral Phenylbutyrate for Treatment of Human 4-Repeat Tauopathies\u201d (PCT\/EP2024\/053388) filed by LMU Munich. In addition, he reports compensation for serving as chief medical officer for MODAG GmbH, is beneficiary of the phantom share program of MODAG GmbH and is inventor in a patent \u201cPharmaceutical Composition and Methods of Use\u201d (EP 22 159 408.8) filed by MODAG GmbH, all activities outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The local Institutional Review Board of LMU confirmed that formal ethics approval was not required for this case report and that this study was carried out in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the relative of the patient since the patient was unable to give written informed consent due to progressive cognitive decline.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"389"}}